Literature DB >> 24186054

Capsule commentary on Turner et al., chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.

Ben A Rich1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24186054      PMCID： PMC3912292          DOI： 10.1007/s11606-013-2675-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  On the edge of the abyss.

Authors:  Eduardo M Fraifeld
Journal:  Pain Med       Date:  2010-06       Impact factor: 3.750

Review 2.  The doctor as double agent.

Authors:  Ben A Rich
Journal:  Pain Med       Date:  2005 Sep-Oct       Impact factor: 3.750

Review 3.  Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties.

Authors:  Robert M Arnold; Paul K J Han; Deborah Seltzer
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

4.  Universal precautions in pain medicine: a rational approach to the treatment of chronic pain.

Authors:  Douglas L Gourlay; Howard A Heit; Abdulaziz Almahrezi
Journal:  Pain Med       Date:  2005 Mar-Apr       Impact factor: 3.750

5.  Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.

Authors:  Judith A Turner; Kathleen Saunders; Susan M Shortreed; Suzanne E Rapp; Stephen Thielke; Linda LeResche; Kim M Riddell; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2013-10-19       Impact factor: 5.128
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.